54 related articles for article (PubMed ID: 6204097)
1. Abnormal expression of vimentin intermediate filaments in human lymphoid cell lines with deletion or translocation of the distal end of chromosome 8.
Dellagi K; Brouet JC; Portier MM; Lenoir GM
J Natl Cancer Inst; 1984 Jul; 73(1):95-100. PubMed ID: 6204097
[TBL] [Abstract][Full Text] [Related]
2. Immunologic markers of Burkitt's lymphoma cells.
Preud'homme JL; Dellagi K; Guglielmi P; Vogler LB; Danon F; Lenoir GM; Valensi F; Brouet JC
IARC Sci Publ; 1985; (60):47-64. PubMed ID: 3864747
[TBL] [Abstract][Full Text] [Related]
3. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
4. Chromosome aberrations acquired in vitro by human B-cell lines. II. Distribution of break points.
Shade M; Woodward MA; Steel CM
J Natl Cancer Inst; 1980 Jul; 65(1):101-9. PubMed ID: 6967123
[TBL] [Abstract][Full Text] [Related]
5. [Translocations t(2;8) and t(8;22) in continuous cell lines of African Burkitt's lymphoma].
Bernheim A; Berger R; Lenoir G
C R Seances Acad Sci D; 1980 Sep; 291(2):237-9. PubMed ID: 6775833
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Szekely L; Pokrovskaja K; Klein G
Cell Growth Differ; 1997 May; 8(5):599-609. PubMed ID: 9149911
[TBL] [Abstract][Full Text] [Related]
7. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
Magrath IT; Pizzo PA; Whang-Peng J; Douglass EC; Alabaster O; Gerber P; Freeman CB; Novikovs L
J Natl Cancer Inst; 1980 Mar; 64(3):465-76. PubMed ID: 6243721
[TBL] [Abstract][Full Text] [Related]
8. Serial cytogenetic studies of nonendemic Burkitt's lymphoma cell lines.
Douglass EC; Magrath IT; Lee EC; Whang-Peng J
J Natl Cancer Inst; 1980 Nov; 65(5):891-5. PubMed ID: 6253706
[TBL] [Abstract][Full Text] [Related]
9. Ecto-5'-nucleotidase. I. Expression in human normal and neoplastic lymphoid cell lines representing sequential stages of B-cell differentiation.
SenGupta S; Hibi T; MacKay A; Markovic V; Stein LD; Sigal N; Gelfand EW; Chechik BE
J Natl Cancer Inst; 1984 Nov; 73(5):1075-80. PubMed ID: 6092765
[TBL] [Abstract][Full Text] [Related]
10. Dok1 expression and mutation in Burkitt's lymphoma cell lines.
Lee S; Huang H; Niu Y; Tommasino M; Lenoir G; Sylla BS
Cancer Lett; 2007 Jan; 245(1-2):44-50. PubMed ID: 16338067
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-13 gene expression by malignant and EBV-transformed human B lymphocytes.
Fior R; Vita N; Raphael M; Minty A; Maillot MC; Crevon MC; Caput D; Biberfeld P; Ferrara P; Galanaud P
Eur Cytokine Netw; 1994; 5(6):593-600. PubMed ID: 7727691
[TBL] [Abstract][Full Text] [Related]
12. [Expression of intermediate filaments (vimentin) in Burkitt's cells].
Dellagi K; Lilienbaum A; Perreau J; Paulin D
Arch Anat Cytol Pathol; 1985; 33(2):97. PubMed ID: 4004357
[No Abstract] [Full Text] [Related]
13. Expression of intermediate filaments in established human lung cancer cell lines. An indicator of differentiation and derivation.
Bergh J; Nilsson K; Dahl D; Andersson L; Virtanen I; Lehto VP
Lab Invest; 1984 Sep; 51(3):307-16. PubMed ID: 6206304
[TBL] [Abstract][Full Text] [Related]
14. Induction of cytoskeleton-associated proteins during differentiation of human myeloid leukemic cell lines.
Bernal SD; Chen LB
Cancer Res; 1982 Dec; 42(12):5106-16. PubMed ID: 6291747
[TBL] [Abstract][Full Text] [Related]
15. [Is there a functional equivalence between abnormalities of the long arm of chromosome 1 and the presence of Epstein-Barr virus in continuous lines of Burkitt's lymphoma?].
Berger R; Bernheim A
C R Acad Sci III; 1984; 298(6):143-5. PubMed ID: 6324967
[TBL] [Abstract][Full Text] [Related]
16. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
[TBL] [Abstract][Full Text] [Related]
17. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
18. Colocalization of nestin and vimentin/desmin in skeletal muscle cells demonstrated by three-dimensional fluorescence digital imaging microscopy.
Sjöberg G; Jiang WQ; Ringertz NR; Lendahl U; Sejersen T
Exp Cell Res; 1994 Oct; 214(2):447-58. PubMed ID: 7925640
[TBL] [Abstract][Full Text] [Related]
19. Chromosome abnormalities in leukemia and lymphoma.
Rowley JD
Ann Clin Lab Sci; 1983; 13(2):87-94. PubMed ID: 6602585
[TBL] [Abstract][Full Text] [Related]
20. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.
Karpova MB; Schoumans J; Blennow E; Ernberg I; Henter JI; Smirnov AF; Nordenskjöld M; Fadeel B
Int J Oncol; 2006 Mar; 28(3):605-17. PubMed ID: 16465364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
